3/26/2019

Hyalose, LLC Selects Echelon Biosciences, Inc. to Serve as Distributor of its Select-HA Products

1/07/2019

Emergent Technologies, Inc. Hires Steven Lloyd Mayer, MD as Chief Medical Officer and Promotes Blake Harlan to Executive Vice President Finance and Operations 

1/09/2017

Pure MHC to Partner with AbbVie on Oncology Research

1/12/2016

Emergent Technologies Company Enters into License Agreement with Xencor

9/14/2015

ETInnovation and Mymantra Srl Form Alliance To Drive Ligneah Technology

6/22/2015

ImmunoCellular Therapeutics Establishes Agreement with Pure MHC for Novel Quality Control Assay for ICT-107 Phase 3 Registrational Trial

4/8/2015

Caisson Biotech Wins Innovation Recognition Award

4/6/2015

AeonClad Coatings Announces New Patent For Method of Using Plasma Deposition

10/21/2014

PureMHC and PhosImmune Working Together On Immunotherapies for Cancer

9/8/2014

Emergent Technologies and Bledisloe & Company Enter Collaboration Agreement to Expand Technology Commercialization Opportunities

3/11/2014

Caisson Biotech Expands HEPtune™ Drug Delivery Deal with Novo Nordisk

7/24/2014

Nature Magazine – Stop the Microbial Chatter – Researchers, including those at Selenium, LTD, are looking for solutions to subvert bacterial signaling.

April 2014

AeonClad – Interactions at the Edges (Nanotech Magazine)

11/8/2013

GMSbiotech and Pure Transplant Solutions Announce Strategic Collaboration

9/19/2013

Emergent Technologies Selected to Serve 50 of the World’s Most Innovative Companies

9/10/2013

Surfacing for Success: Emergent Technologies and KODE Biotech Join Forces to Expand Markets for Platform Technology

5/1/2013

Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers

4/2/2013

Selenium, Ltd. Awarded $500,000 SBIR Grant for Biofouling Prevention Technology

01/15/2013

Caisson’s Heparosan-Based Conjugates (Drug Development and Delivery)

12/11/2012

The Emergent Technologies Innovation Engine Matches Technologies with Entrepreneurs to Bring Novel Products to Market

12/3/2012

Emergent Technologies, Inc. to Hold Incubator Open House

11/12/2012

AeonClad Coatings Deploys Next Generation Reactor to Functionalize PTFE Powder for Application Development and Commercial Testing

11/8/2012

Encapsil Video – Patagonia

11/1/2012

Emergent Technologies, Inc. Launches Life Sciences Business Incubator

10/25/2012

Enavail – Revving Start Up Engines (Fierce Pharma)

10/3/2012

Emergent Technologies, Inc. Announces Executive Appointments to Support Growth Initiatives

10/1/2012

Pure Protein Presents Disease Epitope Discovery Research and Introduces New 120-allele HLA Class I Single Antigen Assay at the 2012 Annual Meeting of the American Society of Histocompatibility and Immunogenetics (ASHI)

9/24/2012

Emergent Technologies, Inc. Appoints Courtney Lambert Vice President of Intellectual Property Services and Acquires Aspect Intellectual Property, Inc.

7/13/2012

AeonClad Coatings Opens New State-of-the-Art R&D Facility to Design and Prototype First of Its Kind Novel Reactors

6/4/2012

Emergent Technologies, Inc. Announces New Board of Directors

5/1/2012

Caisson Biotech Enters Into Development and License Agreement with Novo Nordisk

12/9/2011

Hyalose Awarded $1.23 Mil EDGE Endowment to Build Glyco-Manufacturing Center

12/5/2011

Selenium, Ltd. Leverages Technological Breakthrough in Antimicrobial Applications for new Plastics Initiative

11/28/2011

Selenium, Ltd. Awarded SBIR Grant

11/22/2011

Heparinex, LLC EDGE Fund Endowment

10/23/2011

New Technology Firm Represents First Payoff on Lea County’s Contract With Emergent Technologies, Inc.

4/2/2011

Hyalose Scientists to Present at the 7th Intl. Conference on Hyaluronan

1/6/2011

Accelerate Lea County Fair

10/20/2010

Lea County Commission Announces Management Services Agreement with Emergent Technologies, Inc.’s Innovation Services Group

7/27/2010

Poseidon Sciences and Selenium, Ltd. Announce Collaboration to Develop Environmentally Friendly Coating Technology

6/9/2010

Particle Engineering Company Enavail Announces New cGMP Pharmaceutical Manufacturing Facility to Be Located in the Abilene Life Sciences Accelerator

6/4/2010

Emergent Technologies, Inc. Establishes Technology Evaluation and Research Collaboration Agreement with Merck to identify siRNA Delivery Technologies

4/28/2010

Selenium, Ltd. Awarded NIH Research Grant to Develop Antimicrobial Dental Devices and Water Lines

3/10/2010

Receptor Logic Chief Scientist to Present at Antibody Biology and Engineering Gordon Research Conference

11/17/2009

Appian Labs Announces Development and Commercial License Agreement with Capsugel for the AppiFormTM Modular Release System

11/9/2009

New Start-up Enavail Applies Proprietary Particle Engineering Technologies To Increase Drug Solubility, Stability and Bioavailability

11/3/2009

Emergent Technologies, Inc. Hires Executive Director For the Abilene Life Sciences Accelerator

10/28/2009

Pure Protein Announces Soluble Class II HLA Technology Breakthrough

10/21/2009

Auxano Diagnostics, LLC Announces A New Point-of-Care Indicator System for Dry Eye Syndrome

10/14/2009

Development Corporation of Abilene Announces Management Agreement with Emergent Technologies, Inc.

10/5/2009

Reveal Sciences Launches At-Home Skin Typing and Analysis Kit For Consumers

9/2/2009

Receptor Logic, Inc. Awarded National Cancer Institute Grant

7/13/2009

Kris Looney Promoted to President of Selenium, Ltd.

6/8/2009

Reveal Sciences Puts a New Face on Skin Care Diagnostics with the CareTypeTM Analysis System

6/2/2009

Paula Taylor Promoted to VP of Human Resources for Emergent Technologies

5/13/2009

Receptor Logic, Inc. Launches New Website

5/12/2009

New Vaccine Targets for Influenza and Research Discovered by Pure Vaccine Solutions, LLC Published in PNAS

5/5/2009

William W. Burke Joins Emergent Technologies, Inc. as President

2/3/2009

Heparinex Chief Scientist Receives OCAST Research Funding Award

1/19/2009

New Start-up AeonClad Biomedical Applies Patented Coatings Technology AeonCoatTM to the Drug Delivery and Medical Devices Markets

9/8/2008

Beacon Sciences Announces New Color-Changing Assay for Creatinine

7/27/2008

Testimony of Thomas A. Harlan President and Chief Executive Officer Emergent Technologies, Inc.

6/18/2008

Life Sciences Venture Firm Emergent Technologies, Inc. Selects UT Dallas and UT Southwestern Researchers Gnade and Cadeddu to Receive Opportunity Texas Proof-of-Concept Award

6/17/2008

New Biopharma Company Appian Labs, LLC Provides Drug Design and Delivery Solutions

4/3/2008

Emergent Technologies, Inc. Unveils New Lab Space To Support Life Science Start-Ups

3/20/2008

Reveal Sciences Puts a New Face on Personal Care Innovation

2/25/2008

Emergent Technologies, Inc. Hires Dale Gannaway as Vice President of Business Development

1/25/2008

Emergent Technologies, Inc. Hires Vice President of Business Development

11/12/2007

Selenium, Ltd. Receives STTR Grant from the National Institutes of Health To Develop Antimicrobial Dental Devices and Water Lines

9/4/2007

Emergent Technologies, Inc. Expands Portfolio Company Support Team

7/9/2007

AeonClad Licenses Plasma Deposition Technology from the University of TX at Arlington

5/7/2007

Emergent Technologies Fund IV Raises $27 Million, Focuses Unique Commercialization Model On Biotechnology Within The University Of Texas System Campuses

5/1/2007

Hyalose Chief Scientist Honored at 7th Intl Conference on Hyaluron

4/10/2007

The University of Texas at Austin Licenses Molecular Recognition Assay Technology to Beacon Sciences, LLC

1/11/2007

Austin Life Sciences Venture Capital Firm Emergent Technologies, Inc. Moves Offices to Accommodate Expansion and New Management Team Additions